Late-breaking data demonstrate abbott's freestyle® libre system supports health equity for millions of americans living with diabetes

Abbott park, ill., june 25, 2021 /prnewswire/ -- abbott (nyse: abt) today announced late-breaking data that showed freestyle libre, the world's leading7 continuous glucose monitoring (cgm) system, can support health equity through access to more affordable, life-changing technology for americans living with diabetes, including those in underserved communities.
ABT Ratings Summary
ABT Quant Ranking